CAR T Cells Offer New Hope for Children with Hard-to-Treat Leukemia

CU Anschutz researchers, including CU Cancer Center member Terry Fry, MD, are advancing CAR T cell therapy to improve survival for children with acute lymphoblastic leukemia through next-generation dual-targeting treatments.